Hepatic venous pressure gradient: To measure or not to measure, that is the question

Hepatology

Volumn 32, Issue 5, 2000, Pages 1175-1176

  Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE MONONITRATE; NADOLOL;

BLEEDING; CLINICAL TRIAL; DRUG POTENTIATION; EDITORIAL; HEMODYNAMICS; HEPATIC VEIN; HUMAN; PRIORITY JOURNAL; SCLEROTHERAPY; TREATMENT OUTCOME; VARICOSIS; VASCULAR RESISTANCE; VEIN DILATATION; VEIN LIGATION; VENOUS PRESSURE;

EID: 0033760352     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.20091     Document Type: Article

References (10)

1. Portal pressures, presence of gastroesophageal varices and variceal bleeding
2. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
3. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding
4. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis
5. Propranolol compared with propranolol plus isosorbide 5-mononitrate for portal hypertension in cirrhosis: A randomized controlled study
6. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
7. Effects of isisorbide 5 mononitrate compared to propranolol on first bleeding and long-term survival in cirrhosis
8. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding
9. Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic subjects
10. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension